African-American women with a family history of breast or ovarian cancer are only about one fifth as likely as white counterparts to receive genetic counseling for BRCA 1/2 testing (OR 0.22; 95% CI; 0.12–0.40), according to a recent case-control study from Philadelphia.
African-American women with a family history of breast or ovarian cancer are only about one fifth as likely as white counterparts to receive genetic counseling for BRCA 1/2 testing (OR 0.22; 95% CI; 0.12–0.40), according to a recent case-control study from Philadelphia.
The study included 408 women with a family history of either disease, of whom 217 received genetic counseling and 191 did not. Even after adjusting for the probability of a BRCA 1/2 mutation, socioeconomic characteristics, breast and ovarian cancer risk perception and worry, attitudes about the risk and benefits of BRCA 1/2 testing, and primary-care physician discussion of BRCA 1/2 testing, researchers calculated an odds ratio of 0.28 (95% CI; 0.09–0.89) for African-American women receiving counseling.
Armstrong K, Micco E, Carney A, et al. Racial differences in the use of BRCA1/2 testing among women with a family history of breast or ovarian cancer. JAMA. 2005;293:1729-1736.
Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.
Trimethoprim–sulfamethoxazole not found to increase infant birth weight in HIV cases
July 9th 2025A recent randomized trial found no significant improvement in birth weight or key birth outcomes from antenatal trimethoprim–sulfamethoxazole prophylaxis in human immunodeficiency virus-positive pregnant women.
Read More